Title : Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma.

Pub. Date : 2020 Jan

PMID : 31952784






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma. NAD CD38 molecule Homo sapiens
2 Antibodies targeting CD38, a NAD+-degrading enzyme, have emerged as a promising immunotherapy against multiple myeloma (MM). NAD CD38 molecule Homo sapiens
3 Here, we advocate for the depletion of NAD+ to enhance the efficacy of anti-CD38-based immunotherapies in MM. NAD CD38 molecule Homo sapiens